GLP-1 receptor agonists can promote natriuresis (increased sodium excretion in urine), but clinically meaningful electrolyte disturbances are uncommon unless dehydration or reduced intake occurs
Studies suggest the medication could also help curb alcohol consumption
USADA is a signatory to the World Anti-Doping Code established by the World Anti-Doping Agency (WADA), which means that USADA upholds and enforces WADA rules that govern sport around the world
Tesamorelin protocol: Subcutaneous injection, 5 days on / 2 days off Inject fasted (at least 13 hours after eating) Dosing in the morning (before breakfast) is also an option, but without eating for 30-60 minutes after dose Reconstituted from lyophilized powder with bacteriostatic water Rotate injection sites to prevent irritation Sermorelin protocol: Subcutaneous injection, daily Best administered before bed to align with natural nocturnal GH release Inject fasted (at least 13 hours after eating) Dosing in the morning (before breakfast) is also an option, but without eating for 30-60 minutes after dose Reconstituted from lyophilized powder with bacteriostatic water Upper outer thigh is the preferred injection site What to expect timeline-wise (both peptides): Weeks 14 : Improved sleep quality is often the first noticeable change
Glucagon-like peptide-1 (GLP-1) receptor agonists are a class of medications originally developed for type 2 diabetes management, though some specific formulations are now licensed for weight management in adults with obesity or overweight with weight-related comorbidities
